[HTML][HTML] Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human cell, 2020 - Springer
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

[PDF][PDF] Mesenchymal stem cells and exosome therapy for COVID‑19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - 2020 - osteopathic-medicine.uiw.edu
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

[PDF][PDF] Mesenchymal stem cells and exosome therapy for COVID‑19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - 2020 - researchgate.net
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

[HTML][HTML] Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human Cell, 2020 - ncbi.nlm.nih.gov
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human …, 2020 - pubmed.ncbi.nlm.nih.gov
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

[PDF][PDF] Mesenchymal stem cells and exosome therapy for COVID‑19: current status and future perspective

A Gupta, S Kashte, M Gupta… - Human …, 2020 - exogenix.s3.us-east-2.amazonaws …
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.

A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human Cell, 2020 - europepmc.org
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

[PDF][PDF] Mesenchymal stem cells and exosome therapy for COVID‑19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human Cell, 2020 - academia.edu
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human …, 2020 - pubmed.ncbi.nlm.nih.gov
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

[PDF][PDF] Mesenchymal stem cells and exosome therapy for COVID‑19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human Cell, 2020 - academia.edu
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …